Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.075 CAD | 0.00% |
|
0.00% | +15.38% |
06-26 | Transcript : MediPharm Labs Corp. - Shareholder/Analyst Call | |
06-20 | MediPharm Labs Acquires Rights for Advanced Medical Cannabis Products From Remidose Aerosols | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.38% | 22.18M | |
+28.10% | 5.68B | |
-33.42% | 3.61B | |
-3.33% | 3.11B | |
-26.20% | 2.65B | |
-9.99% | 2.33B | |
+40.09% | 1.89B | |
+40.90% | 1.49B | |
-12.94% | 1.46B | |
+46.67% | 1.37B |
- Stock Market
- Equities
- LABS Stock
- News MediPharm Labs Corp.
- MediPharm Labs to Acquire Rights for Advanced Medical Cannabis Products From Remidose Aerosols